Drug regulator News
Drug pricing regulator NPPA has fixed the ceiling price of 30 more formulations, including those used for treatment of hepatitis, heart conditions, infections, fever and pain.
This year’s list includes painkillers, medicines for anti-allergy, fever, cold, loose motion, constipation, as well as calcium and iron supplements, among others.
Drug major Novartis has been slapped with a Rs 300-crore penalty by drug regulator NPPA for overcharging consumers on sale of Voveran, its best-selling painkiller medicine.
Loading...